Microscopy and image analysis
Fixed cells were imaged with a Leica DMIRE2 laser scanning confocal microscope, using a 63x oil objective (NA 1.40) and 2x zoom. For the quantitative analysis of Smo levels in cilia, all images used for comparisons were taken with identical gain, offset, and laser power settings on the microscope. Non-manipulated images were used for quantitation (ImageJ). A mask was constructed by manually outlining cilia in the acetylated tubulin image and then applied to the corresponding Smo channel image to measure Smo fluorescence at cilia. Local background correction was performed by moving the mask to measure fluorescence at a nearby region, and this value was subtracted from the ciliary Smo fluorescence.
Immunoblotting
Cells were scraped into ice-cold PBS containing Protease Inhibitor Cocktail with EDTA (Roche) and collected as a pellet by centrifugation (1000xg, 10 min, 4 o C). Cells were lysed (1 h, S4 o C), lysate protein concentrations were measured using the bicinchoninic acid assay (Pierce). Samples containing equal total protein were fractionated on an 8% SDS-PAGE gel and transferred to a nitrocellulose membrane for immunoblotting with anti-Gli1 antibody (Cell Signaling, #L42B10, 1:500) and anti-p38 antibody (Abcam, #ab31828, 1:2000) . In figures, vertical gray lines represent noncontiguous lanes from the same immunoblot juxtaposed for clarity.
Ligand affinity chromatography with receptors transfected into 293T cells
70% confluent 6 cm dishes of 293T cells were transfected with 100 ng of DNA encoding YFP-Smo, SSTR3-GFP or HTR6-GFP, and grown to confluence. After harvesting in SEAT buffer, membranes were isolated and a detergent extract prepared and used for ligand affinity chromatography exactly as described in the methods included with the main text.
Liposome expansion assay
10 mg of dioleyl-phosphatidylcholine (DOPC) lipid was lyophilized and reconstituted using 1 ml of a solution of 5 mM CF in EB buffer. The lipid mixture was subjected to 10 freezethaw cycles by repetitive immersion in liquid N 2 and room temperature water. Next the lipid mixture was extruded through a 200 nm filter and run over a column containing Sephadex G-100-120. The second, third and fourth fluorescent fractions (3 drops per fraction) were collected and used in the assay. For both the nat-and ent-20(S)-OHC, solutions of 10 µM were made by diluting pure compound in isopropanol.
At the beginning of the assay, approximately 100 ng of liposomes containing CF was added to a spectrofluorometric cuvette containing 1 ml of EB buffer. Then, 10 µl of 10 µM oxysterol was added and vesicle swelling was monitored for 60 minutes. Fluorescence was normalized to a maximal dequenching value as determined by addition of 10 µl of 20% Triton X-100 at the end of each time series. nat-and ent-20(S)-OHC at 10 µM were tested in triplicate, and for each set of trials an equivalent volume (10 µl) of isopropanol was used as a control. To a stirred solution of the commercially available (3β)-21-(acetyloxy)-3-hydroxypregn-5-en-20-one (1.0 g, 2.67 mmol), in CH 2 Cl 2 (20 mL) under N 2 , was added diisopropylethylamine (0.93 mL, 5.34 mmol). The reaction mixture was cooled to 0°C, and methoxymethyl chloride (0.358 ml, 5.07 mmol) was added dropwise. After 15 min, the reaction was brought to rt, and allowed to stir for 16 h. The reaction was monitored by TLC, and upon completion was cooled to 0°C, and quenched with MeOH (~0.5 mL). The mixture was then diluted with CH 2 Cl 2 (20 mL), and washed sequentially with sat. aqueous NaHCO 3 , (10 mL) and brine (2 x 10 mL). The organic phase was then dried over Na 2 SO 4 , and concentrated in vacuo. The residue was purified by column chromatography on silica gel (EtOAc-hexanes, gradient elution), to yield compound 6 as a white solid (1.07 g, 97%). Based upon known literature procedures 2, 3 , compound 6 (0.78 g, 1.86 mmol) was dissolved in anhydrous Et 2 O (60 mL) at 0°C, under N 2 . LAH (0.28 g, 7.45 mmol) was then added portionwise, and the resulting mixture was brought to rt and allowed to stir for 3 h. Upon completion, the reaction was quenched by the sequential addition of water (0.3 mL) and 15% aq NaOH (0.3 mL), and allowed to stir for 30 min. Additional water (0.9 mL) was then added, and the reaction was stirred another 5 min until white aluminum salts were precipitated. The solids were filtered and rinsed several times with Et 2 O, and the filtrate was then dried over Na 2 SO 4 , and concentrated in vacuo. The residue was purified by column chromatography on silica gel (EtOAc-hexanes, gradient elution), to yield compound 7 as a white solid (0.64 g, 91%). Using a known literature procedure 2 , compound 7 (0.64 g, 1.69 mmol) was dissolved in THF (25 mL), followed by the addition of water (15 mL). Sodium periodate (1.08 g, 5.07 mmol) was then added and the reaction was stirred for 45 min. Upon completion, the reaction mixture was S7 extracted with Et 2 O (4 x 10 mL). The organic fractions were then combined, dried over Na 2 SO 4 , and concentrated in vacuo. The white solid was recrystallized from hexanes, to yield pure compound 8 (0.58 g, 99%). 
(3β, 20R,S)-3-Methoxymethoxy-21-norcholest-5-en-20-ol (9)
In a 2-necked flask equipped with a condenser, was stirred magnesium metal turnings (0.21 g, 8.66 mmol) in anhydrous Et 2 O (20 mL) under N 2 . 1-Bromo-4-methylpentane (1.26 mL, 8.66 mmol) was added, followed by a few drops of 1,2-dibromoethane. The reaction mixture was warmed slightly to 30°C, and stirred vigorously until cloudiness was observed (~1-3 min). The reaction mixture was stirred an additional hr at rt, until the magnesium turnings were consumed, indicating complete formation of the bromo(4-methylpentyl)magnesium reagent. A solution of compound 8 (0.3 g, 0.87 mmol) in anhydrous Et 2 O (6 mL), was then added dropwise to the reaction. The reaction was monitored by TLC, whereupon two new spots were formed. Upon completion, the reaction was quenched with aqueous NH 4 Cl (10 mL). The phases were separated, and the aqueous phase was extracted with Et 2 O (3 x 5 mL). The combined organic fractions were then washed with brine (1 x 10 mL), dried over Na 2 SO 4 , and concentrated in vacuo. The residue was purified by column chromatography on silica gel (acetone-hexane, gradient elution), to yield compound 9 as a separable mixture of diastereomers (20R:20S; 1:2.7) in 98%. Although it is not necessary to separate the diastereomers, 1 H NMR and 13 C NMR data was collected on each pure diastereomer. To a stirred solution of compound 9 (0.24 g, 0.54 mmol) in acetone (7 mL), was added dropwise freshly prepared Jones Reagent (~0.2 mL; 30% CrO 3 ·30% H 2 SO 4 ·40% H 2 O) until the reaction solution turned from green to yellow (~0.2 mL). Monitoring by TLC showed the two diastereomer spots, corresponding to 9, to be converted into one product spot. The reaction was subsequently quenched with isopropanol (3 mL) and the resulting blue-green solution was extracted with CH 2 Cl 2 (4 x 3 mL). The organic layers were filtered through a pad of silica and then concentrated in vacuo. The resulting solid was then dissolved in MeOH (15 mL), whereupon acetyl chloride (0.8 mL) was added dropwise over 15 min, and the reaction was stirred for 2 h. Upon completion, the reaction flask was cooled to 0°C, and was neutralized with sat. aqueous NaHCO 3 (~10 mL). The reaction mixture was extracted with CH 2 Cl 2 (4 x 10 mL), and the organic fractions were combined, dried over Na 2 SO 4 , and concentrated in vacuo. The residue was purified by column chromatography on silica gel (acetone-hexane, gradient elution), to yield compound to yield compound 10 as a white solid (0.16 g, 76% over 2 steps). Following a reported protocol 4 compound 10 (0.14 g, 0.36 mmol), was dissolved in anhydrous Et 2 O(25 mL) under N 2 , and cooled to 0°C. Methylmagnesium bromide; 3M in Et 2 O (0.60 mL, 1.81 mmol) was added dropwise, and the reaction mixture was allowed to stir for 30 min. Upon completion, the reaction was diluted with Et 2 O (15 mL), and quenched with aqueous NH 4 Cl (15 mL). The phases were separated, and the aqueous phase was extracted with Et 2 O (3 x 10 mL). The combined organic fractions were then washed with brine (1 x 15 mL), dried over Na 2 SO 4 , and concentrated in vacuo. The residue was purified by column chromatography on silica gel 
Supplementary scheme 2. Synthesis and characterization of ent-20(S)-OHC (3)

ent-[(3β,20S)-Cholest-5-ene-3,20-diol] (ent-20(S)-OHC)
1-Bromo-4-methylpentane (0.29 mL, 2 mmol) was added to magnesium metal turnings (48.6 mg, 2 mmol) in Et 2 O (10 mL) in a 50-mL round-bottom flask fitted with a condenser and a N 2 filled balloon and the mixture was stirred vigorously. A drop of 1,2-dibromoethane was added to this solution and the mixture was heated at reflux using a hot water bath for few min to initiate reaction of the 1-bromo-4-methylpentane with the magnesium to form bromo(4-methylpentyl)magnesium. The hot water bath was removed and the reaction mixture was stirred at rt for 1 h until the solution became homogenous. ent-Pregnenolone (60 mg, 0.19 mmol), prepared as described previously 5 , was then added as a solid and the cloudy solution was allowed to stir at rt for 18 h under a N 2 atmosphere. The reaction was quenched with sat. aqueous NH 4 Cl solution and extracted with EtOAc (3 x 30 mL). The combined organic extracts were dried over anhydrous Na 2 (SO 4 ) and concentrated to give a white solid. The crude product was purified by silica gel column chromatography using 20-40% EtOAc-hexanes. The desired ent-20(S)-OHC was isolated (45 mg, 59%) and the 13 C NMR spectrum of this product showed that it contained ~20% of the undesired and inseparable ent-20(R)-OHC epimer. Attempts to remove the ent-20(R)-OHC epimer by recrystallization using various solvent conditions were not successful and the following derivatization procedure was required for diastereomer separation.
Purification: The mixture of epimers (45 mg, 0.11 mmol) and 4-nitrobenzoyl chloride (41 mg, 0.22 mmol) in pyridine in the presence of a catalytic amount of 4-dimethylaminopyridine was stirred at rt for 5 hr. The reaction was quenched with sat. aqueous NaHCO 3 and extracted with CH 2 Cl 2 . The combined CH 2 Cl 2 extracts were dried over anhydrous Na 2 (SO 4 ) and concentrated to give a yellow solid, which was purified by silica gel column chromatography using a gradient of 15-30% EtOAc-hexanes, to give an epimeric mixture of the 3-(4-nitrobenzoate) derivatives (50 mg, 82%). The mixture was then crystallized (five times) from MeOH-acetone to obtain the pure enantiomer of the 3- 29 (s, 3H, H-21 
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Supplementary scheme 3. Synthesis and characterization of nat-20(S)-yne (4)
4-Bromo-1-methylsilyl-1-butyne (11)
Compound 11 was prepared according to a known literature procedure 6 . To a solution of commercially available 4-trimethylsilyl-3-butyn-1-ol (2.0 g, 14.06 mmol) in dry dichloromethane (40 mL) at -30°C, was added CBr 4 (8.5 g, 25.6 mmol). The mixture was stirred vigorously for 10 min, until the CBr 4 was completely dissolved, whereupon a solution of PPh 3 (5.53 g, 21.09 mmol) in dry dichloromethane (12 mL) was added dropwise. The reaction mixture was stirred at -30°C for 2 h, after which the temperature was raised to 0°C and was allowed to slowly warm to rt over the next 2 h. Upon completion, the reaction mixture was filtered through a pad of silica, and concentrated in vacuo. The residue was purified by column chromatography on silica gel (100% hexane elution), to yield compound 11 as a colorless liquid (2.16 g, 75%). Analytical data for 11 is as previously reported 6 .
(3β, 17β)-17-(1-hydroxy-1-methylpent-4-ynyl)-androst-5-en-3-ol (nat-20(S)-yne)
nat-20(S)-yne was synthesized following a protocol similar to the synthesis of compound 9. In a 2-necked flask equipped with a condenser, was stirred magnesium turnings (0.45 g, 18.5 mmol) in anhydrous diethyl ether (100 mL) under nitrogen. Compound 11 (3.8 g, 18.5 mmol) was added, followed by a few drops of 1,2-dibromoethane. The reaction mixture was warmed slightly to 30°C, and stirred vigorously until cloudiness was observed. The reaction mixture was stirred an additional hour at rt, until the magnesium turnings were consumed. A solution of pregnenolone (1.0 g, 3.16 mmol) in anhydrous diethyl ether (45 mL), was then added dropwise to the reaction at 0°C. The reaction was then allowed to stir at rt for 1 h. Upon completion, the reaction was cooled to 0°C, diluted with diethyl ether (50 mL), and quenched with aq NH 4 Cl (50 mL). The phases were separated, and the aqueous phase was extracted with Et 2 O (4 x 20 mL). The combined organic fractions were then washed with brine (50 mL), dried over Na 2 SO 4 , and concentrated in vacuo. The residue was passed through a short column of silica gel to remove residual Grignard byproducts, and the crude reaction mixture was then concentrated in vacuo. The reaction mixture was then redissolved in dry THF (60 mL), and cooled to 0°C. Dropwise was added tetrabutylammonium bromide; 1M in THF (5 mL, 5.0 mmol), and the reaction was stirred for 15 min. Remaining at 0°C, the reaction was then quenched with H 2 O (5 mL), and extracted with diethyl ether (2 x 50 mL). The combined organic fractions were then washed with brine, dried over Na 2 SO 4 , and concentrated in vacuo. The residue was purified by column chromatography on silica gel (acetone-hexane gradient elution), to yield almost exclusively the desired S-diastereomer. The pure S-diastereomer was obtained by recrystallizing from methanoldichloromethane. As methanol was unable to be fully evaporated from the crystals, even after extensive drying, the compound was redissolved in dichloromethane and re-evaporated to yield nat-20(S)-yne (0.65 g, 56% 
Supplementary scheme 4. Synthesis and characterization of nat-20(S)-COOH (5) (3β, 17β)-17-(1-Hydroxy-1-methylpent-4-ynyl)-androst-5-en-3-ol-PEG4-carboxylic acidtriazole adduct (nat-20(S)-COOH)
Following known literature procedure 7, 8 , nat-20(S)-yne (10.0 mg, 27.0 µmol) and the commercially available PEG4-NHS-ester azide (10.0 mg, 25.7 µmol) were dissolved in a 1:1 mixture of THF:H 2 O (0.6 mL) at 30°C. To this was added dropwise sodium ascorbate (0.64 mg, 2.6 µmol, dissolved in 0.1 mL H 2 0) followed by CuSO 4 ( 1.02 mg, 5.2 µmol, dissolved in 0.1 mL H 2 0). The reaction mixture was allowed to stir for 5 h at 30°C. Upon completion, the reaction mixture was extracted first with DCM (1 mL), followed by extraction with DCM:MeOH(4:1) (3 x 1 mL). The organic layers were then combined, dried over Na 2 SO 4 , and concentrated in vacuo. The residue was purified by column chromatography on silica gel (ethylacetate-hexane → methanol:H 2 O(50:1)-dichloromethane gradient elution) to yield nat-20(S)-COOH as a white solid (14.3 mg, 84%). In employing these initial reaction conditions, it was found that we had inadvertently hydrolyzed the labile N-hydroxysuccinimide-protecting group, forming instead the carboxylic acid. However, the loss of this protecting group was of no consequence, as this product was still able to be utilized in the subsequent coupling reaction (although it should be noted that in a later refinement of this procedure, it was found that a reaction time of 30 min formed the triazole product with the NHS protecting group intact; in this case, extraction during workup should be done with DCM only, taking care to avoid exposure to protic solvents). Similar to Smo, these two receptors have seven transmembrane segments and localize in primary cilia 14 . Since the antibody used to detect these fusion proteins recognizes YFP and GFP equally well, the signals on the blot are directly comparable. We chose competitor concentrations equal to 1/2x, 1x, 2x, and 5x the IC50 for each inhibitor determined in the Hh reporter assays shown in Figure 3 , main text. From Figure 3 , the IC50s for oxysterol-induced Hh signaling are 10 nM for SANT-1, 50 nM for cyclopamine, and 1 µM for itraconazole. While SANT-1 does have a small effect on YFP-Smo binding, this effect is partial even at a concentration 5-fold higher than its IC50.
